Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up

Journal of Gastrointestinal Surgery

Volumn 11, Issue 8, 2007, Pages 1033-1038

  Fazel, Iraj ^a   Pourshams, Akram ^b   Merat, Shahin ^b   Hemayati, Roya ^b   Sotoudeh, Masoud ^b   Malekzadeh, Reza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Bariatric Surgery; Fatty Liver; Jejunoileal bypass; Liver cirrhosis; Morbid; Obesity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILIOPANCREATIC BYPASS; CHILD; FEMALE; FOLLOW UP; HUMAN; JEJUNOILEAL BYPASS; LIVER; MALE; METHODOLOGY; MIDDLE AGED; MORBID OBESITY; PATHOLOGY;

ADOLESCENT; ADULT; AGED; BILIOPANCREATIC DIVERSION; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; JEJUNOILEAL BYPASS; LIVER; MALE; MIDDLE AGED; OBESITY, MORBID;

EID: 34547173821     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0184-1     Document Type: Article

References (27)

1. Malekzadeh R, Mohamadnejad M, Merat S, Pourshams A, Etemadi A, Obesity pandemic: an Iranian perspective. Archives of Iranian Medicine 2005;8:1-7.
2. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraie M, Semnani S, Brennan P, Boffetta P, Malekzadeh R. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 2006;6:158.
3. Lara MD, Kothari SN, Sugerman HJ. Surgical, management of obesity: a review of the evidence relating to the health benefits and risks. Treatments in Endocrinol 2005;4:55-64.
4. Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 2006;130:1564-1572.
5. Mottin CC, Moretto M, Padoin AV, Kupski C, Swarowsky AM, Glock L, Duval V, da Silva JB. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005;15:788-793.
6. Gastrointestinal surgery for severe obesity. NIH consensus development conference, March 25-27,1991, Nutrition 1996;12:397-404.
7. Brolin RE, Update: NIH consensus conference. Gastrointestinal, surgery for severe obesity. Nutrition 1996;12:403-404.
8. Schneider BE, Mun EC. Surgical management of morbid obesity. Diabetes Care 2005;28:475-480.
9. Holzbach RT. Hepatic effects of jejunoileal bypass for morbid obesity. Am J Clin Nutr 1977;30:43-52.
10. Moxley RT, III, Pozefsky T, Lockwood DH. Protein, nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl. J Med 1974;290:921-926.
11. Geiss DM, Shields S, Watts JD. Reversibility of hepatic failure following jejunoileal bypass. Arch Surg 1976;111:1362-1365.
12. Dean P, Joshi S, Kaminski. DL. Long-term, outcome of reversal of small, intestinal, bypass operations. Am J Surg 1990;159:118-123.
13. Styblo T, Martin S, Kaminski DL. The effects of reversal of jejunoileal bypass operations on hepatic triglyceride content and hepatic morphology. Surgery 1984;96:632-641.
14. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
15. Hamilton DL, Vest TK, Brown BS, Shah AN, Menguy RB, Chey WY. Liver injury with alcoholiclike hyalin, after gastroplasty for morbid obesity. Gastroenterology 1983;85:722-726.
16. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710-723.
17. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
18. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997;94:2557-2562.
19. Mezey E, Imbembo AL, Potter JJ, Rent KC, Lombardo R, Holt PR, Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity. Am. J Clin Nutr 1975;28:1277-1283.
20. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small, intestinal bacterial overgrowth, intestinal, permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001;48:206-211.
21. Shaffer EA. Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. J Clin Gastroenterol. 2006;40:S44-S50.
22. Scopinaro N. Biliopancreatic diversion: mechanisms of action, and long-term results. Obes Surg 2006;16:683-689.
23. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998;8:267-282.
24. Guedea ME, Arribas dA, Solanas JA, Marco CA, Bernado AJ, Rodrigo MA, Diago VA, Diez MM. Results of biliopancreatic diversion, after five years. Obes Surg 2004;14:766-772.
25. Bouldin MJ, Ross LA, Sumrall CD, Loustalot FV, Low AK, Land KK, The effect of obesity surgery on obesity comorbidity. Am J Med Sci 2006;331:183-193.
26. Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V, Kitsanta P, Argyrakos T, Hadjiyannakis E. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 2005;15:1154-1160.
27. Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, Simard S, Marceau P. Effects of surgical, treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004;135:48-58.